Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?

Sánchez-Ruiz de Gordoa J, Zelaya V, Tellechea-Aramburo P, Acha B, Roldán M, López-Molina C, Coca V, Galbete A, Mendioroz M, Erro ME

Open source

DOI
10.3389/fneur.2022.827338
Published
2022
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2022.827338,
  title = {Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?},
  author = {Sánchez-Ruiz de Gordoa J and Zelaya V and Tellechea-Aramburo P and Acha B and Roldán M and López-Molina C and Coca V and Galbete A and Mendioroz M and Erro ME},
  year = {2022},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2022.827338},
  url = {https://doi.org/10.3389/fneur.2022.827338}
}

RIS

TY  - JOUR
TI  - Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?
AU  - Sánchez-Ruiz de Gordoa J
AU  - Zelaya V
AU  - Tellechea-Aramburo P
AU  - Acha B
AU  - Roldán M
AU  - López-Molina C
AU  - Coca V
AU  - Galbete A
AU  - Mendioroz M
AU  - Erro ME
PY  - 2022
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2022.827338
UR  - https://doi.org/10.3389/fneur.2022.827338
ER  - 

APA

J, S. D. G., V, Z., P, T., B, A., M, R., C, L., V, C., A, G., M, M., & ME, E. (2022). Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?. Frontiers in neurology. https://doi.org/10.3389/fneur.2022.827338

Source records